CN1365691A - Nano medicine 'Kunming begonia' and its preparing process - Google Patents
Nano medicine 'Kunming begonia' and its preparing process Download PDFInfo
- Publication number
- CN1365691A CN1365691A CN 01100634 CN01100634A CN1365691A CN 1365691 A CN1365691 A CN 1365691A CN 01100634 CN01100634 CN 01100634 CN 01100634 A CN01100634 A CN 01100634A CN 1365691 A CN1365691 A CN 1365691A
- Authority
- CN
- China
- Prior art keywords
- chinese
- medicine
- temperature
- chinese crude
- prepared slices
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 241000218993 Begonia Species 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 13
- 239000000843 powder Substances 0.000 claims abstract description 11
- 238000001694 spray drying Methods 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 18
- 241001197778 Tripterygium hypoglaucum Species 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 235000008504 concentrate Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 230000008676 import Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000003094 microcapsule Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 229940100688 oral solution Drugs 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 239000003390 Chinese drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 5
- 206010020850 Hyperthyroidism Diseases 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 206010025135 lupus erythematosus Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000011858 nanopowder Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000027496 Behcet disease Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037575 Pustular psoriasis Diseases 0.000 description 1
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 201000010914 pustulosis of palm and sole Diseases 0.000 description 1
- 208000011797 pustulosis palmaris et plantaris Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A nanometre begonia medicine is prepared from the nanometre powder of Kunming begonia through microwave extracting, pressure reduction concentrating, supersonic-jet spray drying. Its grain fineness reaches 1200-1500 meshes and grain diameters are 0.1-200 nm. Its advantages include high biological utilization rate and high curative effect.
Description
The present invention relates to a kind of expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, heat-clearing and toxic substances removing, cure mainly rheumatoid arthritis, hyperthyroidism, the nano medicine ' Kunming begonia ' of lupus erythematosus and chronic nephritis the invention still further relates to the method for this medication preparation.
Tripterygium Hypoglaucum Hutch Tablet is a kind of classical Chinese patent medicine, mainly contains antiinflammatory, immunosuppressant, and antitumor, analgesic, analgesia, effects such as malaria and antifertility are used for rheumatoid arthritis, hyperthyroidism, lupus erythematosus and chronic nephritis etc.But traditional Tripterygium Hypoglaucum Hutch Tablet disintegrate is slower, absorbs not exclusively, and bioavailability is not high, slow curative effect.
The object of the present invention is to provide a kind of bioavailability height, solid dispersion is good, absorbs fully the nano medicine ' Kunming begonia ' of increase evident in efficacy.
Another object of the present invention provides the preparation method of this nano medicine ' Kunming begonia '.
To achieve these goals, the present invention takes following technical scheme:
Medicine of the present invention is to make (consumption is a weight portion) by following component:
100 parts of nanometer Tripterygium hypoglaucumes
Technical scheme of the present invention is based on the modern material technology.One of modern material Developing Trend in Technology is to develop to the more and more littler direction of yardstick.The granule of the past composition material, its size all are at micron or more than the millimeter magnitude, and have occurred the material to the nanoscale development now.Because extremely refinement of granule, the shared percentage by volume of crystal boundary increases, and makes some performance of material that outstanding variation take place.
The property of nano material be since special construction----the material grains size of nano material less than the ultra-micro powder of 100nm, its body surface area is very big, the atom number ratio at crystal boundary place makes it to produce four big effects up to 15--50%: i.e. small-size effect, quantum effect (containing macro quanta tunnel effect), skin effect and interfacial effect.Thereby has the not available physical and chemical performance of traditional material.Nanotechnology will bring a technological revolution of the field of Chinese medicines.
One of method of above-mentioned each component being made medicine of the present invention is:
1. divide and get the Chinese crude drug of respectively distinguishing the flavor of, be processed into the common Chinese decoction pieces according to process of preparing Chinese medicine of Chinese Pharmacopoeia version in 2000.
2. divide and get the common Chinese decoction pieces of respectively distinguishing the flavor of, be processed into the nanometer prepared slices of Chinese crude drugs, its method comprises the following steps:
1. the common Chinese decoction pieces is placed extraction pot, solubilizer also imports microwave extracting, makes its speed with 20--30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃--and 60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃--60 ℃, the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters of effluxvelocities--990 meter per seconds, at 30 ℃--60 ℃ of temperature, under 0 to the 0.05MPa pressure,, promptly make the nanometer prepared slices of Chinese crude drugs with the instantaneous drying of hypersonic velocity.
3. the nanometer prepared slices of Chinese crude drugs (powder) are prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent standard, make pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution.
Two of medicine method for making of the present invention is:
1. be equipped with whole common Chinese decoction pieces in the proportioning ratio, place extraction pot, solubilizer also imports microwave extracting, makes its speed with 20--30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃-60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃--60 ℃, the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters of effluxvelocities--990 meter per seconds, at 30 ℃--60 ℃ of temperature, under 0 to the 0.05MPa pressure,, get Tripterygium hypoglaucum preparation nano powder with the instantaneous drying of hypersonic velocity jet;
4. its nano powder is made aforementioned various preparation according to Chinese Pharmacopoeia version standard preparation in 2000.
The pharmacological effect that above-mentioned two kinds of methods are made nano medicine ' Kunming begonia ' is identical.
A kind of important feature of the present invention is: the made drug material of the present invention has reached nanoscale, common Tripterygium Hypoglaucum Hutch Tablet preparation material is micron or the above particle diameter of millimeter, can only cross the 80-120 mesh sieve, the drug material that the present invention is made, particle diameter is at 0.1--200nm, the overwhelming majority can be crossed the 1200--1500 mesh sieve less than 100nm.
Another important feature of the present invention is: solid preparation of the present invention disintegrate rapidly, and solid dispersion is good in water, absorb fully, the bioavailability height, the pharmacological action effect that mainly contains effective constituent is significantly higher than conventional formulation.
The pharmaceutical preparation that the present invention is made does not need to add any adjuvant, and is more favourable to human body.
The present invention has also created the new drug formulation that powder, suppository, granule, membrane, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution of nano medicine ' Kunming begonia ' etc. is had no precedent in the past.
Pharmaceutical preparation of the present invention can be used for rheumatoid arthritis, hyperthyroidism, lupus erythematosus, idiopathic thrombocytopenic purpura, psoriasis, autoimmune hemolytic anemia, palmoplantar pustulosis, Behcet's syndrome, treatment of conditions such as primary glomerulopathy and malignant tumor, clinical efficacy significantly is better than traditional Tripterygium Hypoglaucum Hutch Tablet.
The present invention's added solvent in microwave extracting is water or ethanol.
The present invention carries out in the concentrating under reduced pressure step at extract, and its concentrating under reduced pressure is conventional scheme.
Embodiment 1:
Prepare nano raw material by preceding method:
100 parts of nanometer Tripterygium hypoglaucumes
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent capsules agent standard, do not add adjuvant, do not granulate, directly divide encapsulated with the fully-automatic capsule racking machine, make capsule, every capsules content of dispersion is the 0.1--0.6 gram, and the patient takes the 1-5 grain at every turn, and take 1-4 every day.
Embodiment 2:
Prepare nano raw material by preceding method:
100 parts of nanometer Tripterygium hypoglaucumes
Production method is as follows:
In the GMP cleaning shop, with the above-mentioned nanometer prepared slices of Chinese crude drugs or the described mixed of powder good after, according to 2000 editions two-shift system agent of Chinese Pharmacopoeia powder needle injection standard, do not add any adjuvant, make nanometer Tripterygium hypoglaucum powder needle injection, every injection content is the 5-20 milligram, each consumption is that 1-2 props up, and use 1-3 every day.
Embodiment 3:
Prepare nano raw material by preceding method:
100 parts of nanometer Tripterygium hypoglaucumes
Production method is as follows:
In the GMP cleaning shop, with the above-mentioned nanometer prepared slices of Chinese crude drugs or powder by described mixed good after, according to 2000 editions two-shift system agent of Chinese Pharmacopoeia membrane standard, filmogen adopts polyvinyl alcohol, make nanometer Tripterygium hypoglaucum membrane, every membrane area size is the 2-100 square centimeter, and content of dispersion is the 1-50 gram, every medicine film pasted 1-7 days, pasted the medicine position: abdominal part, back, chest.
Claims (4)
1, a kind of nano medicine ' Kunming begonia ' is characterized in that it is the medicament that the nano raw material of following weight proportioning is made:
100 parts of nanometer Tripterygium hypoglaucumes
And adopt following method to make: to select the formula Chinese drug material to concoct and be processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1-10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, 30--60 ℃ of temperature, under 0 to the 0.05MPa pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly makes the nanometer prepared slices of Chinese crude drugs.
2, nano medicine ' Kunming begonia ' according to claim 1 is characterized in that said medicine is pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution.
3, the pharmaceutical methods of nano medicine ' Kunming begonia ' according to claim 1 is characterized in that this method comprises the steps: to select the formula Chinese drug material to concoct and is processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1-10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, 30--60 ℃ of temperature, under 0 to the 0.05MPa pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters-990 meter per seconds, promptly makes the nanometer prepared slices of Chinese crude drugs.
4, wherein respectively distinguish the flavor of Chinese medicine in the ratio of prescription or Chinese crude drug concoct be processed into the prepared slices of Chinese crude drugs after mixing, or after making the nanometer prepared slices of Chinese crude drugs mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01100634 CN1365691A (en) | 2001-01-15 | 2001-01-15 | Nano medicine 'Kunming begonia' and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01100634 CN1365691A (en) | 2001-01-15 | 2001-01-15 | Nano medicine 'Kunming begonia' and its preparing process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1365691A true CN1365691A (en) | 2002-08-28 |
Family
ID=4651743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01100634 Pending CN1365691A (en) | 2001-01-15 | 2001-01-15 | Nano medicine 'Kunming begonia' and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1365691A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110025629A (en) * | 2019-05-23 | 2019-07-19 | 河南大学 | Application of the hall crabapple flower flower polysaccharide in terms of preparing medicament for immunity enhancement |
-
2001
- 2001-01-15 CN CN 01100634 patent/CN1365691A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110025629A (en) * | 2019-05-23 | 2019-07-19 | 河南大学 | Application of the hall crabapple flower flower polysaccharide in terms of preparing medicament for immunity enhancement |
| CN110025629B (en) * | 2019-05-23 | 2021-03-26 | 河南大学 | Application of filamental flowering crab polysaccharide in preparing immunity enhancing medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1365691A (en) | Nano medicine 'Kunming begonia' and its preparing process | |
| CN1364543A (en) | Nano apricot kernel and perilla antitussive medicine and its preparing method | |
| CN1368066A (en) | Nano ginseng-pearl medicine and its preparing process | |
| CN1362191A (en) | Nano Folium Ginkgo medicine and its preparation | |
| CN1368295A (en) | Nano medicine 'Xiangdan' and its preparing process | |
| CN1365711A (en) | Nano vomiting nut medicine and its preparing process | |
| CN1368310A (en) | Nano medicine 'Tianma Mihuanjun' and its preparing process | |
| CN1368215A (en) | Nano medicine 'Compound Dahuang' and its preparing process | |
| CN1368267A (en) | Nano snow lotus medicine and its preparing process | |
| CN1368075A (en) | Nano medicine 'Relinqing' and its preparing process | |
| CN1368162A (en) | Nano medicine 'Jingangteng' and its preparing process | |
| CN1365807A (en) | Nano medicine 'Kanlisha' and its preparing process | |
| CN1368341A (en) | Nano medicine 'Pitong' and its preparing process | |
| CN1368127A (en) | Nano medicine 'Liandanxiaoyan' and its preparing process | |
| CN1368266A (en) | Nano medicine 'Xuedansu' and its preparing process | |
| CN1362119A (en) | Nano natural indigo medicine and its preparation | |
| CN1365693A (en) | Nano medicine for treating cervical cancer and its preparing process | |
| CN1368052A (en) | Nano medicine 'Gansukang' and its preparing process | |
| CN1365725A (en) | Nano medicine 'Gengyi' and its preparing process | |
| CN1365786A (en) | Nano medicine 'Anwei' and its preparing process | |
| CN1368120A (en) | Nano medicine 'Jinsuanping' and its preparing process | |
| CN1365737A (en) | Nano medicine 'Jiawei Guiqi' and its preparing process | |
| CN1368073A (en) | Nano medicine 'Ziyun' and its preparing process | |
| CN1368113A (en) | Nano Medicine 'Xuezaisheng' and its preparing process | |
| CN1362219A (en) | Nano Zhichuanling medicine for treating asthma and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |